0000950170-24-081522.txt : 20240703
0000950170-24-081522.hdr.sgml : 20240703
20240703161506
ACCESSION NUMBER: 0000950170-24-081522
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Graves Kurt
CENTRAL INDEX KEY: 0001406337
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 241100289
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS INC.
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
ownership.xml
4
X0508
4
2024-07-01
0001609809
Seres Therapeutics, Inc.
MCRB
0001406337
Graves Kurt
C/O SERES THERAPEUTICS, INC.
101 CAMBRIDGE PARK DRIVE
CAMBRIDGE
MA
02140
true
false
false
false
false
Stock Option (right to buy)
0.72
2024-07-01
4
A
false
64564
0.00
A
2034-06-30
Common Stock
64564
64564
D
The option vests and becomes exercisable in four equal quarterly installments occurring on October 1, 2024, January 1, 2025, April 1, 2025 and July 1, 2025, provided that if the Company's 2025 annual meeting of stockholders occurs before July 1, 2025, the final quarterly vesting installment will vest on the day immediately prior to the date of such annual meeting, in each case, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date.
/s/ Thomas J. DesRosier, Attorney-in-Fact
2024-07-03